![Manil Subesinghe](/newimages/folsm/person-profile/bmeis/manil-subesinghe.xc06d26ec.png?f=webp)
Biography
Manil Subesinghe trained at Guy’s, King’s & St. Thomas’ (GKT) School of Medicine qualifying in 2004. He completed general medical training in Leeds and London, and clinical radiology training in West Yorkshire. He developed a subspecialty interest in Radionuclide Radiology and completed a 1 year PET-CT fellowship in Leeds. He was appointed as a consultant radiologist in Oxford in 2014 and then to his current post as a Clinical Lecturer in PET imaging at KCL in 2017.
His research interests include the role of functional and molecular imaging in cancer. He is a co-author of the 2015 British Thoracic Society guidelines for the investigation and management of pulmonary nodules.
He has lectured at regional and national meetings on various aspects of PET-CT in oncology and delivers lectures on the Nuclear Medicine: Science & Practice post-graduate course run by KCL. He is an OSCE examiner and interviewer for the GKT School of Medical Education. He is a member of the British Nuclear Medicine Society (BNMS) Scientific and Educational Committee (SEC) and Clinical Radiology Professional and Learning Development Committee of the Royal College of Radiologists (RCR).
Research
![GI cancer programme 780x440](/newimages/research/thumb/gi-cancer-programme-780x440.x6b890afb.png?width=380&height=215&fit=crop&f=webp)
Programme in Gastrointestinal Cancer
The Programme in GI Cancer focuses on GI tract diseases, mostly cancer and oesophago-gastric cancer. This group spans a broad field of interests, promoting collaborative working within KCL, nationally and internationally.
Research
![GI cancer programme 780x440](/newimages/research/thumb/gi-cancer-programme-780x440.x6b890afb.png?width=380&height=215&fit=crop&f=webp)
Programme in Gastrointestinal Cancer
The Programme in GI Cancer focuses on GI tract diseases, mostly cancer and oesophago-gastric cancer. This group spans a broad field of interests, promoting collaborative working within KCL, nationally and internationally.